Diffusion Pharmaceuticals Inc (DFFN.OQ)
DFFN.OQ on NASDAQ Stock Exchange Capital Market
0.22USD
3:59pm EST
0.22USD
3:59pm EST
Change (% chg)
$0.02 (+7.60%)
$0.02 (+7.60%)
Prev Close
$0.20
$0.20
Open
$0.20
$0.20
Day's High
$0.22
$0.22
Day's Low
$0.19
$0.19
Volume
93,007
93,007
Avg. Vol
47,278
47,278
52-wk High
$2.08
$2.08
52-wk Low
$0.19
$0.19
About
Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)
Overall
| Beta: | -1.45 |
| Market Cap(Mil.): | $14.69 |
| Shares Outstanding(Mil.): | 50.64 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| DFFN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 95.96 | 30.88 |
| EPS (TTM): | -0.45 | -- | -- |
| ROI: | -78.11 | 0.60 | 13.80 |
| ROE: | -155.53 | -2.18 | 15.29 |
Estimates